Recently, it was reported that ESR2 signalling in female ovariectomized mice reduced adiposity and insulin resistance [7]; thus, challenging the paradigm that high ESR2 expression always confers metabolically detrimental effects and highlighting the importance of appropriate experimental models when investigating oestrogen receptors. The gene discussed is ESR2; the disease is Insulin resistance.